¹ Mlcek, J., Jurikova, T., Skrovankova, S., & Sochor, J. (2016). Quercetin and its anti-allergic immune response. Molecules, 21(5), 623. doi:10.3390/molecules21050623
² Kimata, M., Shichijo, M., Miura, T., Serizawa, I., Inagaki, N., & Nagai, H. (2000). Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clinical and Experimental Allergy, 30(4), 501-508. doi:10.1046/j.1365-2222.2000.00768.x
³ Galli, S. J., & Tsai, M. (2012). IgE and mast cells in allergic disease. Nature Medicine, 18(5), 693-704. doi:10.1038/nm.2755
⁴ Shoba, G., Joy, D., Joseph, T., Majeed, M., Rajendran, R., & Srinivas, P. (1998). Influence of piperine on the pharmacokinetics of curcuminin animals and human volunteers. Planta Medica, 64(4), 353-356. doi:10.1055/s-2006-957450
⁵ Haftcheshmeh, S. M., Mirhafez, S. R., Abedi, M., Heydarlou, H., Shakeri, A., Mohammadi, A., & Sahebkar, A. (2022). Therapeutic potency ofcurcumin for allergic diseases: A focus on immunomodulatory actions. Biomedicine and Pharmacotherapy, 154, 113646. doi:10.1016/j.biopha.2022113646
⁶ Lazar, V., Ditu, L. M., Pircalabioru, G. G., Picu, A., Petrescu, C. D., & Cucu, N., et al. (2018). Aspects of gut microbiota and immunesystem interactions in infectious diseases, immunopathology, and cancer. Frontiers in Immunology, 9, 1830. doi:10.3389/fimmu.2018.01830
⁷ Rostaher, A., Morsy, Y., Favrot, C., Unterer, S., Schnyder, M., Scharl, M., & Fischer, N. M. (2022). Comparison of the gut microbiome betweenatopic and healthy dogs—Preliminary data. Animals, 12(18), 2377. doi:10.3390/ani12182377
⁸ Marsella, R., Santoro, D., & Ahrens, K. (2012). Early exposure to probiotics in a canine model of atopic dermatitis: A preliminary study.Veterinary Immunology and Immunopathology, 146(2), 185-189. doi:10.1016/j.vetimm.2012.02.013
⁹ Marsella, R., Santoro, D., Ahrens, K., et al. (2009). Evaluation of Lactobacillus rhamnosus GG for the prevention of atopy in dogs: Arandomized, double-blind, placebo-controlled trial. American Journal of Veterinary Research, 70(6), 735-740. doi:10.2460/ajvr.70.6.735
¹⁰ Saevik, B. K., Bergvall, K., Holm, B. R., et al. (2004). A randomized, controlled study to evaluate the steroid-sparing effect of essentialfatty acid supplementation in the treatment of canine atopic dermatitis. Veterinary Dermatology, 15(3), 137-145. doi:10.1111/j.1365-3164.200400378.x
¹¹ Popa, I., Pin, D., Remoue, N., et al. (2011). Analysis of epidermal lipids in normal and atopic dogs, before and after administration of anoral omega-6/omega-3 fatty acid feed supplement: A pilot study. Veterinary Research Communications, 35, 501-509. doi:10.1007/s11259-011-9493-7
¹² Maurer, H. R. (2001). Bromelain: Biochemistry, pharmacology and medical use. Cellular and Molecular Life Sciences, 58(9), 1234-1245. doi:101007/PL00000936
¹³ Secor, E. R., Carson, W. F., Cloutier, M. M., Guernsey, L. A., Schramm, C. M., Guernsey, A. A., et al. (2005). Bromelain exertsanti-inflammatory effects in an ovalbumin-induced murine model of allergic airway disease. Cellular Immunology, 237(1), 68-75. doi:10.1016/jcellimm.2005.11.002
¹⁴ Kimata, M., Shichijo, M., Miura, T., Serizawa, I., Inagaki, N., & Nagai, H. (2000). Effects of luteolin, quercetin and baicalein on IgE-mediated mediator release from human cultured mast cells (supporting detail). Clinical and Experimental Allergy, 30(4), 501-508. doi:10.1046/j.1365-2222.2000.00768.x